BRD - Groupe Société Générale SA
BRD - Groupe Société Générale SA
10/18/2022 | Press release | Distributed by Public on 10/17/2022 23:31
Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating[...]
Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following[...]
Results from a Phase 1 First in human Study of Pemivibart: an[...]
BRD - Groupe Société Générale SA
10/18/2022 | Press release | Distributed by Public on 10/17/2022 23:31
Please select the service you want to use:
Smartlinks | BRD - Groupe Société Générale SA | Société Générale SA | Company News | Issue of Shares and Capital Increase | Company Appointments | Corporate Officer Change | Financial Services | Banking | Public Companies | Banks | London Stock Exchange (LSE) | Bursa de Valori Bucuresti (BVB) | Cboe Off Exchange | Cinnober BOAT
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact